Furosemide Kabi

Quick links to important sections

Furosemide Kabi

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Furosemide Kabi

Furosemide Kabi: A Quick Introduction

Property Description
Active Ingredient Furosemide (INN)
Form Solution for injection
Pharmacological Class Loop Diuretic
Primary Therapeutic Goal Treating severe fluid retention
Origin Synthetic compound

Furosemide Kabi is a generic, prescription-only medication containing the potent active ingredient furosemide in the form of a sterile solution for injection. This formulation is intended for rapid and controlled administration, typically via the intravenous (IV) or intramuscular (IM) route, and is primarily used in clinical settings. The name "Kabi" designates the specific pharmaceutical manufacturer, while Furosemide is the universally recognized International Nonproprietary Name (INN) for the active substance.

What Type of Medicine is Furosemide Kabi?

Furosemide Kabi belongs to the pharmacological class known as loop diuretics, which are distinguished by their high efficacy in removing excess fluid. The core compound, furosemide, is a small-molecule, chemically manufactured, synthetic substance. Its designation as a high-potency loop diuretic is crucial for conditions requiring swift reduction of body water and salt.

What Conditions is Furosemide Kabi Used For?

The general therapeutic purpose of Furosemide Kabi is the management of severe, acute fluid retention (edema). It is most frequently administered when rapid intervention is necessary to address fluid overload associated with conditions such as acute pulmonary edema or severe decompensation related to chronic heart, liver, or kidney problems. Its primary function is to promote immediate and substantial diuresis (increased urine output), quickly alleviating the physical effects of significant fluid accumulation.

Regulatory References

  1. Furosemide: MedlinePlus Drug Information
  2. Furosemide - StatPearls - NCBI Bookshelf
  3. Furosemide Vitabalans - referral

What side effects are possible with Furosemide Kabi?

Possible Side Effects and Safety Information

The safety profile of Furosemide Kabi (furosemide) is officially documented by regulatory agencies, reflecting its primary action as a potent loop diuretic. The documented adverse reactions are categorized by frequency and the physiological system affected, providing a structured view of possible risks.


Frequency-Classified Adverse Reactions

The most commonly documented effects are linked to the medicine's influence on fluid balance. Very Common (ge 1/10) effects include electrolyte disturbances (such as hypokalemia or low potassium) and dehydration. Effects classified as Common (ge 1/100 to < 1/10) include hypotension (low blood pressure) and increases in blood creatinine and urea.

Less frequently documented effects include: Uncommon (ge 1/1,000 to < 1/100) reactions like certain skin reactions and hearing disorders (ototoxicity). Rare (ge 1/10,000 to < 1/1,000) documented reactions include specific blood disorders (e.g., leukopenia) and acute interstitial nephritis.


Serious Safety Considerations

The official labeling notes several serious adverse reactions. These include the potential for irreversible deafness associated with ototoxicity and rare but severe hematological conditions, such as agranulocytosis. Severe skin conditions like Stevens-Johnson Syndrome (SJS) are also documented in the safety profile. For individuals with pre-existing hepatic impairment, there is an explicit regulatory caution regarding the risk of hepatic encephalopathy.

Safety Constraints and Patterns

The safety profile includes restrictions on use, classifying conditions like anuria (absence of urine production) and severe hypovolemia or dehydration as contraindications. The documentation also notes time-related safety patterns, specifically that the risk of ototoxicity is increased when the medicine is administered intravenously at very high rates.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage of Furosemide Kabi is characterized by an extension of its therapeutic effect, resulting in severe profound diuresis and dehydration. Officially documented manifestations of overdose include blood volume reduction (hypovolemia) and hypotension.

Documented Clinical Manifestations

Classification Manifestations
Physiological Signs Severe electrolyte imbalance (hypokalemia, hyponatremia), azotemia, dizziness, and extreme tiredness.
Severe Outcomes Circulatory collapse, vascular thrombosis and embolism, and ototoxicity (hearing impairment) are documented complications.

Required Emergency Actions

Regulatory documents mandate that the individual must seek immediate medical attention for suspected overdose. Treatment is strictly supportive, focused on the replacement of excessive fluid and electrolyte losses; no specific antidote is known. Emergency services must be contacted immediately if symptoms involve collapse, a seizure, trouble breathing, or an inability to be awakened. Frequent monitoring of serum electrolytes and blood pressure is required during management.

Population-Specific Notes

Elderly patients are documented to have an increased risk of severe dehydration leading to circulatory collapse and vascular events. Patients with pre-existing hepatic cirrhosis are at risk of hepatic encephalopathy and coma due to sudden alterations in fluid balance.

Therapeutic Uses of Furosemide Kabi

What Furosemide Kabi Treats: Main Uses and Benefits

Furosemide is used in situations involving certain distressing symptoms across two therapeutic domains. It is primarily applied for the supportive management of symptoms related to excess fluid accumulation (oedema) and the symptomatic management of high blood pressure (hypertension).


Easing Discomfort from Fluid Build-up (Oedema)

This domain covers the supportive management of symptoms related to systemic imbalance, specifically excess fluid accumulation (oedema or edema). This is often relevant in conditions where functional stability becomes affected and characterized by periods of heightened symptoms. Furosemide is generally used to help address symptom clusters that may become intense or disruptive, such as noticeable swelling. It provides support that helps ease the overall symptom burden and contributes to improved day-to-day comfort during periods of heightened symptoms.


Supportive Relief for High Blood Pressure Symptoms

Furosemide is also applied across domains where additional symptomatic support is needed for managing high blood pressure (hypertension). This use is relevant when supportive symptom management is appropriate for symptoms related to heightened physiological activity. It may assist with maintaining functional stability and general well-being by supporting the body during these episodes.


Quick Facts: Furosemide Uses
Used in contexts marked by increased discomfort or tension, assisting with the management of symptoms associated with systemic imbalance and heightened physiological activity.

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

The eligibility for Furosemide Kabi is strictly defined by regulatory documents, primarily focusing on patient safety regarding fluid volume and electrolyte status.

Populations for Whom Use is Contraindicated Use of Furosemide Kabi is absolutely prohibited in certain conditions, as listed in official labeling:

  • Anuria (complete absence of urine production).
  • Severe Hypersensitivity to furosemide or related sulfonamide derivatives.
  • Severe Hypovolaemia or Dehydration.
  • Severe Electrolyte Imbalances, such as severe hypokalaemia or hyponatraemia.
  • Hepatic Coma or pre-comatose states, due to the risk of worsening neurological function.
  • Renal failure that is unresponsive to furosemide treatment.

Conditional and Restricted Use The medicine is indicated for adult and pediatric patients with edema. However, specific groups must be managed with caution:

  • Older Adults: Use requires cautious dosage adjustment due to a heightened risk of symptomatic hypotension and volume depletion.
  • Hepatic Impairment: Patients with hepatic cirrhosis and ascites must be closely monitored to prevent the induction of hepatic encephalopathy.
  • Pediatric Use: Intravenous administration in children and adolescents is generally restricted to exceptional circumstances in some regions.
  • Reproductive Status: Furosemide Kabi is not recommended during pregnancy unless compelling medical reasons dictate use, and it is contraindicated for women who are breastfeeding as it may inhibit milk production.

What should I know about interactions with other medicines?

Furosemide Kabi can interact with several other medications, affecting their efficacy or increasing the risk of adverse effects. It is important to inform your doctor or pharmacist about all prescription, over-the-counter medicines, and supplements you are currently taking.

Increased Risk of Toxicity or Side Effects

Concomitant Medicine Class Potential Risk or Outcome
Aminoglycoside antibiotics (e.g., Gentamicin, Tobramycin) and Cisplatin Increased risk of ototoxicity (hearing damage).
Lithium Reduced excretion of Lithium, leading to a high risk of Lithium toxicity.
ACE inhibitors and Angiotensin II Receptor Blockers (ARBs) Risk of severe hypotension (very low blood pressure) and potential kidney problems.
Cyclosporine Increased risk of gouty arthritis due to elevated uric acid levels.
Digoxin and other drugs causing hypokalemia (low potassium) Increased risk of cardiac arrhythmias (irregular heartbeat).

Reduced Efficacy

Concomitant Medicine Class Potential Risk or Outcome
Non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., Ibuprofen, Naproxen) May reduce the diuretic effect of Furosemide Kabi and increase the risk of kidney dysfunction.
Sucralfate Can reduce the absorption and effectiveness of Furosemide Kabi. Should be taken at least 2 hours apart.
Phenytoin May reduce the effectiveness of Furosemide Kabi.

Also, be aware that long-term use of laxatives or certain corticosteroids may increase the risk of low potassium levels (hypokalemia) when combined with Furosemide Kabi.

Mechanism of Action

Furosemide Kabi's action is defined by a precise cascade that begins with targeted ion transport disruption in the kidney and culminates in rapid shifts in fluid and circulatory dynamics.

Primary Ion Transport Blockade

Furosemide Kabi acts at the molecular level by competitively inhibiting the Na^+- K^+-2 Cl^- cotransporter ( NKCC2), the key ion channel in the kidney's thick ascending limb. By blocking the binding site for chloride ( Cl^-), the drug prevents the reabsorption of sodium ( Na^+), potassium ( K^+), and Cl^- ions back into the bloodstream. This molecular blockade interrupts the transport of these electrolytes.


Osmotic Cascade and Volume Modulation

The inhibition of the NKCC2 transporter causes a significant accumulation of unreabsorbed salts within the renal tubules. This high concentration of solutes creates an intense osmotic gradient that forces a substantial volume of water to be retained in the tubular fluid, bypassing the body's normal reabsorption processes. This shift in fluid homeostasis leads to a marked increase in the volume of urine output (diuresis) and increased excretion of salts (natriuresis).


Systemic Preload Adjustment

Independent of the urinary fluid movement, the drug also modulates the systemic circulation. Furosemide's mechanism involves an early, acute vascular effect, which is partially mediated by the local release of prostaglandin E2 ( PGE2) in the kidney. This modulation widens blood vessels, causing a decrease in the pressure and volume returning to the heart chambers, known as cardiac preload reduction.

Dosage and Administration Information

Furosemide Kabi is supplied as a sterile solution for injection, which is administered parenterally, primarily via the intravenous (IV) route. The intramuscular (IM) route is typically restricted to exceptional circumstances where IV or oral administration is not feasible.

The medicine is used on a titration-based schedule. The typical initial adult IV dose is 20 mg to 40 mg given as a slow injection. Subsequent doses may be increased by 20 mg increments after a minimum interval of 2 hours to assess response, up to a maximum daily dose of 1500 mg.

The administration process is highly procedural to ensure proper delivery. IV bolus doses must be administered slowly over 1 to 2 minutes to control the rate. For continuous IV infusions, the rate must strictly not exceed 4 mg per minute. Due to the solution's properties, it requires careful selection of compatible diluents (such as 0.9% Sodium Chloride) and must not be mixed with acidic preparations to maintain solution stability.

Dosage regimens are adjusted for specific populations. Older adults typically begin with a lower starting dose of 20 mg daily. Pediatric patients initiate therapy at 1 mg/kg via slow IV or IM injection, with increases not occurring sooner than two hours. Once the acute need for the parenteral form has resolved, the use of the injection is replaced with an oral formulation as soon as clinically appropriate.

Recent Clinical Evidence

Furosemide Kabi: Recent Clinical Evidence


Evidence for Use in Managing Acute Fluid Retention (Oedema)

Research has studied Furosemide extensively in research exploring its role in managing severe fluid retention (oedema) associated with conditions like heart failure, liver cirrhosis, or serious kidney problems. Research efforts include Randomized Controlled Trials (RCTs) and Pharmacodynamic (PD) studies.

Researchers monitored outcomes such as acute measurements of Urine Output (Diuresis) and long-term measures including hospitalization rates and patient-reported outcomes describing perceived discomfort and quality of life. The body of research for this core use includes the highest standard of available evidence. However, some findings describing rapid physiological changes stem primarily from older foundational research and small-scale studies.


Evidence for Use in Supportive Management of High Blood Pressure (Hypertension)

Furosemide was studied for its application in managing high blood pressure (hypertension). The evidence base consists of Foundational Clinical Trials and Systematic Reviews. Studies monitored measurements of Systolic and Diastolic Blood Pressure, particularly in patient groups where volume overload was associated with their hypertension.

Research highlights that the drug's short duration of action means that the data show patterns related to less sustained 24-hour control, often limiting its role to volume-sensitive patients. The evidence supporting this indication is primarily descriptive and is often observational.


Research in Specific Populations and Evidence Gaps

Research has explored the use of Furosemide in several distinct groups beyond the general adult population, including specific older adults and pediatric patients. Follow-up durations in studies are highly varied, ranging from acute checks (within hours) to more long-term follow-up in comparative trials.

However, the evidence base for certain narrow subgroups is limited. Additionally, comparative evidence is lacking for many direct, long-term assessments, and some understanding of acute actions relies on older studies. Findings describe group patterns, and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Furosemide: A Review of Its Use in Infants and Children - PEDIATRIC PHARMACOTHERAPY (Review of pharmacokinetics in special populations)
  2. Diuretic Treatment in Heart Failure: A Practical Guide for Clinicians (Includes half-life and bioavailability comparison)

Frequently Asked Questions (FAQ)

Common questions about Furosemide Kabi (FAQ)

Q: What is the main reason Furosemide Kabi is prescribed?

Furosemide is officially indicated for treating edema (fluid retention or swelling) associated with certain medical conditions, such as heart failure, liver disease, or kidney disease. It is also approved for treating high blood pressure (hypertension), sometimes used alone or in combination with other medications.

Q: Is Furosemide Kabi known as a 'water pill'?

Yes, Furosemide Kabi belongs to a class of medications called diuretics. Diuretics are widely known as 'water pills' because they work on the kidneys to increase the amount of urine the body produces, helping to remove excess fluid.

Q: Why is it important to take Furosemide Kabi regularly?

According to official product information, when Furosemide is used for high blood pressure, it helps to control the condition rather than curing it. Therefore, maintaining consistent use, as prescribed, is commonly required to help manage blood pressure and prevent serious related complications.

Q: Does Furosemide Kabi treat high blood pressure, or is it for swelling?

Furosemide is approved by regulatory bodies for treating both high blood pressure (hypertension) and swelling (edema). It is often a key therapy for removing fluid associated with various heart, liver, and kidney conditions.

Q: How does Furosemide Kabi compare generally to other diuretics?

Furosemide is classified as a potent loop diuretic, meaning it works in a specific part of the kidney called the Loop of Henle and has a strong fluid-removing effect. Official warnings indicate that it can cause significant fluid and electrolyte loss if not administered carefully.

Q: Is Furosemide Kabi different from generic furosemide?

Furosemide Kabi is a brand-specific name for the active drug, furosemide. The active ingredient is the same as the generic drug, and both contain the same drug formulation.

Q: Can Furosemide Kabi cause fatigue or low energy?

Yes, regulatory documents list fatigue, weakness, or unusual tiredness as reported side effects. These symptoms are often related to the changes in the body's fluid and electrolyte balance caused by the medication.

Q: Do people feel dizzy after taking Furosemide Kabi?

Yes, dizziness, lightheadedness, or fainting may occur. This is often due to a drop in blood pressure or blood volume, especially when moving suddenly from a sitting or lying position to standing.

Q: What are the most common signs that the body is reacting to Furosemide Kabi?

Common reactions listed in official documents include frequent urination, dizziness, headache, and potential for thirst or dry mouth. The increased urination is the expected therapeutic effect, while the others may be related to fluid shifts.

Q: Is it normal to feel increased thirst while taking Furosemide Kabi?

Yes, increased thirst and dry mouth are noted side effects that can occur from fluid loss. While often minor, severe or persistent thirst is information that may be discussed with a healthcare provider.

Q: Can Furosemide Kabi affect my blood sugar levels?

Official labeling notes that Furosemide may cause an increase in blood glucose levels and can alter glucose tolerance test results. Patients with diabetes are sometimes advised to monitor their sugar levels closely.

Q: Are there any common foods or drinks that should be avoided when taking Furosemide Kabi?

Official guidance often notes the need for individualized dietary management, which may include salt restriction. Patients are also advised to be mindful of foods high in potassium because of the drug's effect on this electrolyte.

Q: Does Furosemide Kabi interact with common pain relievers like ibuprofen?

Yes, Furosemide can interact with non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen. The combination may potentially decrease the expected diuretic (fluid-removing) effect of Furosemide.

Q: Is there a concern when combining Furosemide Kabi with supplements like potassium or magnesium?

Official documents indicate that measures like potassium supplementation are sometimes required to help manage or prevent low potassium levels (hypokalemia), which is a risk with Furosemide.

Q: Can taking Furosemide Kabi affect the results of blood tests?

Yes, Furosemide can change the levels of various substances in the body, requiring the results of blood or urine tests to be checked regularly. These tests help monitor blood glucose, electrolyte levels (like potassium and sodium), and kidney function.

Q: Why are people often asked about their hearing when taking this medication?

Furosemide has been linked to ototoxicity, which is a risk of hearing impairment. This can cause tinnitus (ringing in the ears) or hearing loss, especially when the drug is given rapidly, in high doses, or to patients with existing kidney issues.

Q: What is the evidence base for using Furosemide Kabi in managing heart failure?

Furosemide is a well-established medication that is officially indicated for treating the edema (fluid retention) associated with congestive heart failure. It is often a key part of the therapeutic strategy to manage fluid volume.

Q: Are there long-term studies on the use of Furosemide Kabi?

Official labels advise that all patients should be observed regularly during prolonged use. This monitoring is required because of the potential for rare, long-term issues affecting the blood, liver, or kidneys, indicating the need for ongoing evaluation.

Q: How long does it typically take for Furosemide Kabi to start having an effect?

The onset of action depends on the route of administration. Following an intravenous (IV) injection, the peak diuretic effect typically starts relatively quickly, often within 30 minutes.

Q: How long do the effects of Furosemide Kabi last after taking a dose?

The duration of the fluid-removing effect following an intravenous (IV) dose is generally up to two hours. This fast action and relatively short duration are typical of loop diuretics.

Q: Is it common for Furosemide Kabi to cause changes in the skin?

Reported side effects include common skin reactions such as rash, itching (pruritus), or hives. Official documents also note the rare occurrence of severe skin reactions like Stevens-Johnson Syndrome.

Q: Can Furosemide Kabi cause problems with muscle cramps?

Yes, muscle pains or cramps are noted as potential signs of an electrolyte imbalance, such as low potassium (hypokalemia), which can occur with this type of diuretic therapy.

Q: Are there specific instructions for what to do if side effects occur?

Official patient information often describes symptoms related to excessive fluid or electrolyte loss, such as feeling dizzy when standing up. Simple actions, like getting up slowly (to manage low blood pressure), are generally suggested for managing minor fluid-related symptoms.

Q: Does Furosemide Kabi have a risk of causing sunburn or sun sensitivity?

Yes, official labels advise that the drug may increase the skin's sensitivity to sunlight. This means that a person's skin may be more prone to sunburn or photosensitivity while using Furosemide.

Q: Can I take Furosemide Kabi if I have a sulfur allergy?

Regulatory documents indicate a potential link between the drug and certain allergies. Patients who are allergic to sulfonamide derivatives (a class of sulfa drugs) may also have an allergic reaction to Furosemide.

Q: What kind of monitoring is usually required for people taking Furosemide Kabi?

Regular check-ups are required, usually involving blood or urine tests, to monitor health markers. This monitoring ensures the medication is working correctly and checks for changes in blood pressure, kidney function, and electrolyte levels.

Q: Is it possible to become dehydrated while taking Furosemide Kabi?

Yes, official warnings highlight that Furosemide is potent and that excessive urination can lead to a state of dehydration and low blood volume. Special attention must be paid to monitoring fluid status.

Q: Does Furosemide Kabi cause any changes in mood or sleep?

Adverse effects related to the central nervous system are reported in official labeling. These effects may include drowsiness, restlessness, or, rarely, confusion.

Q: What is Furosemide Kabi approved to treat according to regulatory bodies?

According to regulatory approvals, Furosemide is indicated for the treatment of edema (fluid retention) and for managing hypertension (high blood pressure).

Q: Is Furosemide Kabi used for conditions other than swelling or fluid retention?

Yes, official indications confirm that Furosemide is also used to treat high blood pressure (hypertension), which is a condition separate from general fluid retention or swelling.

Q: Are there specific official warnings for people with liver conditions taking Furosemide Kabi?

Yes, regulatory documents include warnings for patients with severe liver conditions like hepatic cirrhosis. Sudden changes in fluid and electrolyte balance can be risky and may precipitate hepatic coma.

Q: What are the signs of low potassium related to Furosemide Kabi?

Signs of low potassium (hypokalemia) listed in regulatory warnings include dry mouth, thirst, muscle weakness, lethargy, and muscle cramps. These signs or symptoms indicate the need for prompt evaluation.

Q: Can Furosemide Kabi be used during pregnancy or breastfeeding?

For pregnancy, the drug is generally reserved for situations where the potential benefit is judged to outweigh the potential risk to the developing fetus. For breastfeeding, the drug passes into breast milk and may reduce milk production, so caution is advised.

Q: What is the difference between loop diuretics and other types of diuretics?

Furosemide is classified as a loop diuretic because it works specifically in the Loop of Henle in the kidney. This mechanism of action makes it highly effective at promoting water and salt excretion, making it one of the most potent classes of diuretics.

Q: Is it necessary to drink more water when taking Furosemide Kabi?

While the regulatory label emphasizes that dehydration must be avoided, the decision regarding fluid intake is personalized. Any advice to increase or restrict fluid intake should be guided by a healthcare provider.

Q: Can Furosemide Kabi interact with herbal remedies?

Yes, some regulatory guidance advises caution, noting that certain herbal products may interact with Furosemide. These interactions can potentially alter the drug's intended action or worsen side effects.

Q: Is Furosemide Kabi considered a high-alert medication?

The FDA label includes a prominent WARNING stating Furosemide is a potent diuretic that can lead to profound fluid and electrolyte loss. This underscores the need for careful medical supervision and individualized dosage.

Q: Why is regular blood pressure checking important while using Furosemide Kabi?

Regular monitoring of blood pressure is required as part of the management plan. This is essential to ensure the medication is effectively controlling the patient's blood pressure and to check for potential low blood pressure (hypotension) caused by fluid loss.

Q: Does Furosemide Kabi interact with lithium?

Yes, Furosemide interacts significantly with the mood stabilizer lithium. The diuretic reduces the body's ability to clear lithium, which can cause increased levels of lithium in the blood and raise the risk of toxicity.

Q: What are the known limitations of Furosemide Kabi treatment?

Limitations noted in official documents include the drug's potential for reduced effectiveness in patients with very low protein levels (hypoproteinemia). It is also important to remember the drug controls high blood pressure but does not cure it.

Q: Is Furosemide Kabi related to sulfa drugs?

Yes, Furosemide is chemically related to sulfonamides, commonly known as sulfa drugs. Official documents warn that patients with an allergy to sulfonamides may also be allergic to Furosemide.

Q: Can I drive or operate machinery while taking Furosemide Kabi?

Official information advises using caution when driving or operating hazardous machinery while on Furosemide. This is because the medication can cause side effects like dizziness, lightheadedness, or fainting.

Q: Is fluid restriction required while on Furosemide Kabi?

Furosemide is a potent fluid remover, and official warnings stress that severe dehydration must be avoided. The decision to restrict or increase fluids is a complex medical decision that is individualized by a healthcare provider.

Q: What are the typical storage conditions mentioned in the official documents?

The injection form is typically required to be stored at controlled room temperature. It must also be protected from light to maintain the stability of the solution.

Q: Does Furosemide Kabi have a boxed warning in its official documentation?

Yes, the FDA label includes a prominent WARNING (which is equivalent to a boxed warning) that emphasizes the risk of profound water and electrolyte depletion. This underscores the need for careful dose titration and patient monitoring.

Q: What are the official recommendations for alcohol consumption while using Furosemide Kabi?

Official drug interaction guides warn that alcohol and Furosemide may have additive effects in lowering blood pressure. This combination that may increase the risk of symptoms like severe dizziness, lightheadedness, or fainting.

Q: Can Furosemide Kabi be used to treat swelling in the legs only?

Furosemide is approved to treat edema (fluid retention), which commonly presents as swelling in the legs. However, the treatment is aimed at the underlying medical condition causing the fluid retention, not just the physical location of the swelling.

Q: Does the time of day matter when taking Furosemide Kabi?

For patients using the oral form, official guidelines often advise avoiding administration near bedtime. This recommendation helps prevent increased urination from interrupting sleep.

How should Furosemide Kabi be stored and disposed of?

How to Store and Dispose of Furosemide Kabi Injection

Official regulatory guidelines strictly define how Furosemide Kabi Solution for Injection must be stored and discarded.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Environment Must be stored in the original outer carton to protect from light. Do not refrigerate or freeze the product.
After Dilution Use the diluted solution immediately. If immediate use is not possible, the solution has a limited stability period (e.g., 24 hours).
Child Safety Keep the medicine out of the sight and reach of children.

Disposal Instructions

Furosemide Kabi is for single use only, and any unused remainder must be discarded. Disposal of the unused or expired product and waste material must be conducted in accordance with local pharmaceutical waste requirements. It must not be disposed of via wastewater or common household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Furosemide Kabi found in:

A-Z Index: